|
| Home : Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting |
|
Nov 03
2022 |
Acepodia to Present Preclinical Data on its Gamma Delta T cell Therapy Candidate, ACE1831, at 2022 SITC Annual Meeting |
|
ALAMEDA, Calif., and TAIPEI, Nov. 3, 2022 /PRNewswire/ -- Acepodia, a clinical-stage biotechnology company developing first-in-class cell therapies with its unique antibody-cell conjugation (ACC) technology to address gaps in cancer care, today announced the upcoming poster presentation... |
|
|
|
| Source:https://www.prnewswire.com:443/news-releases/acepodia-to-present-preclinical-data-on-its-gamma-delta-t-cell-therapy-candidate-ace1831-at-2022-sitc-annual-meeting-301667249.html |
| |
|
Related News
|
» NBA, Nets face calls for stronger response to Kyrie Irving tweet
» Orexo Interim Report Q3 2022
|
|
|
